Efficacy and safety of biweekly i.v. administrations of the Aurora kinase inhibitor danusertib hydrochloride in independent cohorts of patients with advanced or metastatic breast, ovarian, colorectal, pancreatic, small-cell and non-small-cell lung cancer: a multi-tumour, multi-institutional phase II study

P. Schöffski, Benjamin Besse, Thomas Gauler, Maja J.A. de Jonge, Giovanni Scambia, Armando Santoro, C. Davite, M.G. Jannuzzo, Anna Petroccione, J.-P. Delord

Annals of Oncology · 2014 · 57 citations · 12 references

DOIFull text

Open access

Concepts

References

12